Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 3, 2010, Pages 415-420

  Li, Qinglin ^a   Cheng, Hui ^a   Zhu, Guoqi ^a   Yang, Li ^a   Zhou, An ^a   Wang, Xiaoshan ^a   Fang, Nianbai ^b   Xia, Lunzhu ^a   Su, Jingjing ^a   Wang, Mei ^a   Peng, Daiying ^a   Xu, Qi ^c  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^b HUBEI UNIVERSITY   (China)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Anticancer effect; Apoptosis; Cell cycle; Gambogenic acid

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLIN D1; CYCLOOXYGENASE 2; GAMBOGENIC ACID; MESSENGER RNA; UNCLASSIFIED DRUG; NEO-GAMBOGIC ACID; PLANT EXTRACT; PLANT RESIN; TERPENE; XANTHENE DERIVATIVE; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; GARCINIA; GENETICS; ISOLATION AND PURIFICATION; LUNG NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYTOTHERAPY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; GARCINIA; GENE EXPRESSION REGULATION; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PHYTOTHERAPY; PLANT EXTRACTS; RESINS, PLANT; RNA, MESSENGER; TERPENES; XANTHENES; XANTHONES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77649204661     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.415     Document Type: Article

References (28)

1. Lei Q. M., Liu J. M., Chin. J. Cancer Prevent. Treat., 10, 216-219 (2003).
2. Lei Q. M., Liu J. M., Gong D. E., Chin. J. Tumor., 7, 282 (1985).
3. Cao J. M., Chen F. H., Zhang T., Jiangxi. Med., 3, 1-2 (1980).
4. Lu G. B., Yang X. X., Huang Q. S., Acta Pharm. Sin., 19, 636-639 (1984).
5. Qu B. X., Hao X. G., Li D. H., Chin. J. Clin. Oncol., 18, 50-52 (1991).
6. Qu B. X., Ji Y. J., Zhang P., Yu S. P., Li D. H., Chin. J. Clin. Oncol., 18, 53-56 (1991).
7. Cheng H., Peng D. Y., Wang X. S., Huang P., Li Q. L., Chin. Trad. Herb. Drugs, 39, 236-241 (2008).
8. Ofir R., Seidman R., Rabinski T., Krup M., Yavelsky V., Weinstein Y., Wolfson M., Cell. Death Differ., 9, 636-642 (2002).
9. Cui Q., Tashiro S., Onodera S., Minami M., Ikejima T., Biol. Pharm. Bull., 30, 859-864 (2007).
10. Zhao L., Guo Q. L., You Q. D., Wu Z. Q., Gu H. Y., Biol. Pharm. Bull., 27, 998-1003(2004).
11. Asano J., Chiba K., Tada M., Yoshii T., Phytochemistry, 41, 815-820 (1996).
12. Liang J., Pan Y., Zhang D., Guo C., Shi Y., Wang J., Chen Y., Wang X., Liu J., Guo X., Chen Z., Qiao T., Fan D., FASEB J., 21, 2247-2256 (2007).
13. Bissery M. C., Guénard D., Guéritte-Voegelein F., Lavelle F., Cancer Res., 51, 4845-4852 (1991).
14. Sawaoka H., Tsuji S., Tsujii M., Gunawan E. S., Sasaki Y., Kawano S., Hori M., Lab. Invest., 79, 1469-1477 (1999).
15. Zeng S., Liu D., Ye Y., Wang L., Wang W., J. Chin. Med. Mater., 27, 842-845 (2004).
16. Wu Z. Q., Guo Q. L., You Q. D., Zhao L., Gu H. Y., Biol. Pharm. Bull., 27, 1769-1774 (2004).
17. Cheng Y. F., Zhu G. Q., Wang M., Cheng H., Zhou A., Wang N., Fang N., Wang X. C., Xiao X. Q., Chen Z. W., Li Q. L., Neurosci. Res., 63, 52-58 (2009).
18. Jo E. H., Kim S. H., Ra J. C., Kim S. R., Cho S. D., Jung J. W., Yang S. R., Park J. S., Hwang J. W., Aruoma O. I., Kim T. Y., Lee Y. S., Kang K. S., Cancer Lett., 230, 239-247 (2005).
19. Hartmann A., Troadec J. D., Hunot S., Kikly K., Faucheux B. A., Mouatt-Prigent A., Ruberg M., Agid Y., Hirsch E. C., J. Neurosci., 21, 2247-2255 (2001).
20. Liu W., Guo Q. L., You Q. D., Zhao L., Gu H. Y. , Yuan S. T., World J. Gastroenterol., 11, 3655-3659 (2005).
21. Bacus S. S., Gudkov A. V., Lowe M., Lyass L., Yung Y., Komarov A. P., Keyomarsi K., Yarden Y., Seger R., Oncogene, 20, 147-155 (2001).
22. Lowe S. W., Lin A. W., Carcinogenesis, 21, 485-495 (2000).
23. Pu P. Y., Zhang Y. Z., Jiang D. H., Chin. J. Cancer Res., 12, 257-262 (2000).
24. Schwartz G. K., Shah M. A., J. Clin. Oncol., 23, 9408-9421 (2005).
25. Yamamoto H., Ochiya T., Takeshita F., Toriyama-Baba H., Hirai K., Sasaki Hid., Sasaki Hir., Sakamoto H., Yoshida T., Saito I., Terada M., Cancer Res., 62, 1641-1647 (2002).
26. Gautschi O., Ratschiller D., Gugger M., Betticher D. C., Heighway J., Lung Cancer, 55, 1-14 (2007).
27. Koroleva O. A., Tomlinson M., Parinyapong P., Sakvarelidze L., Leader D., Shaw P., Doonan J. H., Plant Cell, 16, 2364-2379 (2004).
28. Sievers E. M., Bart R. D., Backhus L. M., Lin Y., Starnes M., Castanos R., J. Thorac. Cardiovasc. Surg., 129, 1242-1249 (2005).